Lv1
80 积分 2024-02-21 加入
Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trial
3个月前
已完结
Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trial
3个月前
已完结
Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases
7个月前
已完结
Systemic administration of an RNA binding and cell-penetrating antibody targets therapeutic RNA to multiple mouse models of cancer
8个月前
已完结
皖公网安备34019202002308
